Planning and prioritizing direct acting antivirals treatment for HCV patients in countries with limited resources: lessons from the Egyptian experience.
about
Sofosbuvir Plus Daclatasvir in Treatment of Chronic Hepatitis C Genotype 4 Infection in a Cohort of Egyptian Patients: An Experiment the Size of Egyptian Village.Epidemiology and Elimination of HCV-Related Liver DiseaseChallenge of hepatitis C in Egypt and hepatitis B in MauritaniaTowards hepatitis C virus elimination: Egyptian experience, achievements and limitationsGeneric sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
P2860
Planning and prioritizing direct acting antivirals treatment for HCV patients in countries with limited resources: lessons from the Egyptian experience.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Planning and prioritizing dire ...... from the Egyptian experience.
@en
Planning and prioritizing dire ...... from the Egyptian experience.
@nl
type
label
Planning and prioritizing dire ...... from the Egyptian experience.
@en
Planning and prioritizing dire ...... from the Egyptian experience.
@nl
prefLabel
Planning and prioritizing dire ...... from the Egyptian experience.
@en
Planning and prioritizing dire ...... from the Egyptian experience.
@nl
P2093
P50
P1476
Planning and prioritizing dire ...... s from the Egyptian experience
@en
P2093
Aisha Elsharkawy
Ashraf Omar Abdelaziz
Ayman Yosry
Gamal Esmat
Kadry El-Saeed
Khaled Kabil
Magdy El-Serafy
Manal Hamdy El-Sayed
Mohamed Kamal Shaker
Rasha Eletreby
P304
P356
10.1016/J.JHEP.2017.11.034
P577
2017-12-06T00:00:00Z